We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVE.L Regulatory News (EVE)

  • There is currently no data for EVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eve Sleep plc: Trading Update, Board Appointment, Grant of Share Options

29 May 2020 07:01

Eve Sleep plc (EVE) Eve Sleep plc: Trading Update, Board Appointment, Grant of Share Options 29-May-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


eve Sleep plc ("eve" or the "Company")

 

Trading update, Board appointment and Grant of share options

 

Trading in-line, healthy cash position

 

eve Sleep ("eve", the "Company), the direct to consumer sleep wellness brand operating in the UK, Ireland (together the UK&I) and France announces a trading update for the four months ended 30 April 2020 (the Period), ahead of its Annual General Meeting being held at 10.00am this morning. The Company also announces that Cheryl Calverley will formally be appointed to the Board as of 1 June 2020 and as part of her remuneration for her new role has been granted options over the Company's shares. Cheryl became the Company's Chief Executive Officer on 12 May 2020 following a formal handover period.

 

 

Highlights

 

Group revenues in-line with expectations, including good trading in May

 

Positive marketing contribution for the Period, representing profit after all direct costs including marketing but before central overheads

 

Cash burn in the Period averaged £0.1m per month

 

Net cash at 30 April 2020 of £7.5m (31 December 2019: £8.0m)

 

Legacy Woodford shareholding cleared1

 

 

Covid-19 update

 

The business has adapted quickly and effectively to the lockdown in March. The shift to home working has been seamless with no noticeable impact on productivity. Having previously right sized the business in late 2019 there has been no need to furlough any team members. Supply chain issues have been modest and well managed and our manufacturing partners have now resumed production.

 

Whilst weekly trading patterns have varied substantially across recent months, overall revenues are in-line with the Board's expectations, with improving trading in April continuing into May, after the disruption of the initial lock-down period from the middle of March. Sales of eve's award winning premium mattress range and bedframes continue to exhibit strong demand, and the Company has experienced an increase in sales of its pillows, bedding, toppers and single mattresses as households adapt to life in lockdown. Most importantly, with the focus on moving to profit and cash generation, the Company has achieved a positive marketing contribution for the Period. eve has now delivered a positive marketing contribution for the eight month period commencing September 2019.

 

As an online focused business, eve has undoubtedly benefitted from the lack of high street competition following the lockdown in March. Notwithstanding resilient trading to date, there is clearly uncertainty around the trading environment for the remaining seven months of the financial year, including the ongoing strength of consumer demand and industry competition, as store based retailers advance their plans to re-open as early as June.

 

Appointment to the Board and Grant of share options

 

 

As noted above, the Company is also pleased to announce, that Cheryl Calverley will formally be appointed to the Board as of 1 June 2020. Cheryl became the Company's Chief Executive Officer on 12 May 2020 following a formal handover period.

 

Cheryl has been granted options to subscribe for an aggregate of 3,750,000 ordinary shares in the Company (the "Options") at an exercise price of 0.1p (with a start date for vesting purposes of 1 June 2020). The Options vest from their start date on a straight-line basis over a three-year vesting period in monthly increments, subject to meeting certain performance criteria. Following the grant of the options, Cheryl Nicola Calverley (née Bouton), 40, holds nil ordinary shares in the Company, 204,167 vested unexercised options and 4,295,833 unvested options due to vest over the next 3 years. There is no further information required to be disclosed under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Separately, Nikki Crumpton and Tom Enraght-Moony, Non-executive Directors of the Company, were both granted options to each subscribe for an aggregate of 180,000 ordinary shares in the Company, vesting over three years at an exercise price of 0.1p.

Cheryl Calverley, CEO of eve Sleep commented:

"eve has shown remarkable resilience through this complex period, with a robust supply chain and collaborative and responsive team culture. We have grasped the opportunity offered by the depressed TV market to run our existing, highly effective campaigns in both the UK and France, which have seen a strong response and resulted in further gains in marketing efficiency.  Our differentiated strategy, focused on the wider sleep wellness market, continues to resonate well with customers and is achieving ongoing improvements in the customer repeat rate and the sales contribution of wider sleep products beyond mattresses.

I am confident that our online focused proposition, core strategy and breadth of our award winning product suite will enable us to navigate ongoing market uncertainty and the return of primarily store based competition. We remain obsessive about seamlessly delivering better sleep for our customers, and carefully and systematically growing our impact on sleep through products, partners and markets."

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.

 

For enquiries, please contact:

eve Sleep plc

Cheryl Calverley, Chief Executive Officer 

Tim Parfitt, Chief Financial Officer

 

via M7 Communications LTD

finnCap Ltd - Nominated Adviser and Broker

Matt Goode / Hannah Boros - Corporate Finance

Alice Lane - Equity Capital Markets

Tel: +44 (0)20 7220 0500

 

M7 Communications LTD - PR/IR

Mark Reed

Tel: +44(0)7903 089 543

 

 

 

Footnote

1The Woodford holding stood at 45% of outstanding share capital following the equity fund raise in February 2019. This holding was subsequently transferred to three asset managers, Jupiter, Link and Standard Life Aberdeen. As at 28 May 2020 all three asset managers have exited their holding, removing what was a substantial stock overhang

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

Name

Cheryl Calverley

 

2

Reason for the notification

 

a)

Position / status

CEO

 

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

eve Sleep plc 

b)

LEI

2138007BAC29AUXWQE67

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each ("Ordinary Shares")

 

Identification code

ISIN:  GB00BYWMFT51

b)

Nature of transaction

Issuance of options over Ordinary Shares

c)

 Price(s) and volume(s)

Price(s)

Volume(s)

n.a

3,750,000 

 

d)

Aggregated information

N.A

e)

Date of the transaction

28 May 2020

f)

Place of the transaction

N.A

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

Name

Tom Enraght-Moony

2

Reason for the notification

 

a)

Position / status

NED

 

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

eve Sleep plc 

b)

LEI

2138007BAC29AUXWQE67

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each ("Ordinary Shares")

 

Identification code

ISIN:  GB00BYWMFT51

b)

Nature of transaction

Issuance of options over Ordinary Shares

c)

 Price(s) and volume(s)

Price(s)

Volume(s)

n.a

180,000

 

d)

Aggregated information

N.A

e)

Date of the transaction

1 April 2019

f)

Place of the transaction

N.A

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

Name

Nikki Crumpton

2

Reason for the notification

 

a)

Position / status

NED

 

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

eve Sleep plc 

b)

LEI

2138007BAC29AUXWQE67

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each ("Ordinary Shares")

 

Identification code

ISIN:  GB00BYWMFT51

b)

Nature of transaction

Issuance of options over Ordinary Shares

c)

 Price(s) and volume(s)

Price(s)

Volume(s)

n.a

180,000

 

d)

Aggregated information

N.A

e)

Date of the transaction

1 April 2019

f)

Place of the transaction

N.A

 

 
   

 

 

 

 

 

 

 


ISIN:GB00BYWMFT51
Category Code:TST
TIDM:EVE
LEI Code: 2138007BAC29AUXWQE6
Sequence No.:66704
EQS News ID:1058369
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
18th Nov 20227:00 amRNSCancellation - ESR 2022 plc
17th Oct 20227:30 amRNSSuspension - Eve Sleep PLC
17th Oct 20227:00 amRNSAppointment of Administrators
28th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
27th Sep 20226:17 pmRNSForm 8.3 - eve Sleep plc
27th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
27th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
26th Sep 20224:40 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:30 amRNSForm 8.3 - eve Sleep plc
23rd Sep 20229:17 amRNSForm 8.3 - eve Sleep plc
21st Sep 20228:47 amRNSForm 8.3 - eve Sleep plc
20th Sep 20222:05 pmRNSSecond Price Monitoring Extn
20th Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:05 amRNSSecond Price Monitoring Extn
20th Sep 202211:00 amRNSPrice Monitoring Extension
20th Sep 20229:51 amRNSForm 8.3 - eve Sleep plc
20th Sep 20227:01 amEQSEve Sleep plc: Interim Results and FSP Update
15th Sep 20225:36 pmRNSForm 8.3 - Eve Sleep Plc
12th Sep 20227:56 amRNSForm 8.3 - eve Sleep plc
5th Sep 202210:24 amRNSForm 8.3 - eve Sleep plc
2nd Sep 20229:54 amRNSForm 8.3 - eve Sleep plc
26th Aug 20225:04 pmRNSForm 8.3 - eve Sleep plc
25th Aug 202212:46 pmRNSForm 8.3 - eve Sleep plc
17th Aug 20228:50 amRNSForm 8.3 - eve Sleep plc
11th Aug 20227:00 amRNSForm 8.3 - eve Sleep plc
9th Aug 20229:18 amRNSForm 8.3 - eve Sleep plc
4th Aug 20222:08 pmRNSForm 8.3 - eve Sleep plc
4th Aug 20222:03 pmRNSForm 8.3 - eve Sleep plc
4th Aug 20221:59 pmRNSForm 8.3 - eve Sleep plc
21st Jul 20227:00 amEQSEve Sleep plc: Trading and FSP Update and Non-Executive Director Board Change
11th Jul 202211:20 amRNSForm 8.3 - eve Sleep plc
11th Jul 20227:00 amRNSForm 8.3 - eve Sleep plc
24th Jun 20223:33 pmGNWForm 8.3 - Octopus Investments - Eve Sleep plc
21st Jun 20228:00 amEQSForm 8.3 - 4 Ventures Limited - Form 8.3
16th Jun 20226:22 pmEQSForm 8.3 - Eve Sleep plc: Paul Pindar Form 8.3
9th Jun 20227:00 amRNSForm 8.3 - eve Sleep plc
7th Jun 20226:05 pmEQSEve Sleep plc: AMENDMENT - PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
7th Jun 20224:24 pmRNSForm 8.3 - eve Sleep plc
7th Jun 20222:06 pmRNSSecond Price Monitoring Extn
7th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 20221:50 pmEQSEve Sleep plc: PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
7th Jun 20229:03 amRNSForm 8 (DD) - eve Sleep plc
6th Jun 20223:09 pmGNWForm 8.3 - Octopus Investments - Eve Sleep plc
6th Jun 20229:05 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
6th Jun 20227:00 amEQSEve Sleep plc: Review of Strategic Options, Formal Sale Process and Trading Update
19th May 20224:21 pmEQSEve Sleep plc: Result of AGM
16th May 20224:30 pmEQSEve Sleep plc: Posting of 2021 Annual Report and Financial Statements and Notice of Annual General Meeting
3rd May 20223:07 pmEQSEve Sleep plc: Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.